A 2023 study of Medicaid patients in Kentucky and Ohio found that patients beginning buprenorphine treatment through telehealth were more likely to remain in treatment for 90 days than patients beginning treatment in non-telehealth settings.
These findings suggest that telehealth can help overcome barriers such as transportation, geographic distance and demanding work schedules.
Original sources
- Hammerslag et al. JAMA Network Open (2023). Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees.
- NIH summary of the research
Explore treatment options
Explore online Suboxone treatment · See all research updates
Research summaries are provided for education and do not replace individualized medical advice.
Request an appointment